LPP and hypertensive disorder: The LPP-mediated degradation of LPA is susceptible to the phosphatase inhibitor sodium orthovanadate (Na3VO4) [35] and to propranolol [20,36], better known as a classical β-adrenoceptor blocking agent e.g. used in the treatment of hypertension.